SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022912
Filing Date
2020-05-07
Accepted
2020-05-07 16:28:00
Documents
67
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aldx-10q_20200331.htm 10-Q 1685456
2 EX-10.32 aldx-ex1032_101.htm EX-10.32 124935
3 EX-31.1 aldx-ex311_8.htm EX-31.1 17219
4 EX-31.2 aldx-ex312_6.htm EX-31.2 17439
5 EX-32.1 aldx-ex321_7.htm EX-32.1 8999
6 GRAPHIC grhxm5ynva1h000001.jpg GRAPHIC 15747
  Complete submission text file 0001564590-20-022912.txt   5596788

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT aldx-20200331.xml EX-101.INS 1054354
8 XBRL TAXONOMY EXTENSION SCHEMA aldx-20200331.xsd EX-101.SCH 42626
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20200331_cal.xml EX-101.CAL 43588
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20200331_def.xml EX-101.DEF 132306
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20200331_lab.xml EX-101.LAB 334048
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20200331_pre.xml EX-101.PRE 252485
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 20856903
SIC: 2834 Pharmaceutical Preparations